About AVT
Browse Articles
Authors
Customer Services

Advanced Publication

Antiviral Therapy publishes articles here before they are finally assigned to an issue. The articles are listed by online publication date and can be cited via a doi.
 
Displaying 49 results:

Original article

Association of characteristics of HBV quasispecies with hepatitis B surface antigen seroconversion after pegylated interferon-alpha-2a treatment in child patients

Juncheng Yang, Guifeng Yang, Haitang He, Lu Ning, Zhihua Liu, Qunfang Fu, Haitao Chen, Haohui Deng, Zhanhui Wang, Kangxian Luo

10.3851/IMP3262


Free
Correction

Correction: DARING-B: discontinuation of effective entecavir or tenofovir disoproxil fumarate long‑term therapy before HBsAg loss in non-cirrhotic HBeAg‑negative chronic hepatitis B

George V Papatheodoridis, Eirini I Rigopoulou, Margarita Papatheodoridi, Kalliopi Zachou, Vassilios Xourafas, Nikolaos Gatselis, Emilia Hadziyannis, John Vlachogiannakos, Spilios Manolakopoulos, George N Dalekos

10.3851/IMP3261


Short communication

Carotid magnetic resonance imaging in persons living with HIV and 10-year atherosclerotic cardiovascular disease risk score

Thomas C Mee, Julia Aepfelbacher, Rebecca Krakora, Cheryl Chairez, Nina Kvaratskhelia, Bryan Smith, Veit Sandfort, Colleen Hadigan, Caryn Morse, Dima A Hammoud

10.3851/IMP3258


Original article

The effect of curing hepatitis C with direct-acting antiviral treatment on endothelial function

Joshua S Davis, Melissa Young, Sandra Lennox, Tracey Jones, Kim Piera, Robert Pickles, Stephen Oakley

10.3851/IMP3257


Original article

DARING-B: discontinuation of effective entecavir or tenofovir disoproxil fumarate long-term therapy before HBsAg loss in non-cirrhotic HBeAg-negative chronic hepatitis B

George V Papatheodoridis, Eirini I Rigopoulou, Margarita Papatheodoridi, Kalliopi Zachou, Vassilios Xourafas, Nikolaos Gatselis, Emilia Hadziyannis, John Vlachogiannakos, Spilios Manolakopoulos, George N Dalekos

10.3851/IMP3256


Original article

Antiviral effects of Cacicol®, an heparan sulfate biomimetic for corneal regeneration therapy, for herpes simplex virus type 1 and varicella zoster virus infection

Claire Deback, Antoine Rousseau, Magali Breckler, Lucie Molet, David Boutolleau, Sonia Burrel, Anne-Marie Roque-Afonso, Marc Labetoulle

10.3851/IMP3254


Original article

Interim analysis of a 3-year follow-up study of NS5A and NS3 resistance-associated substitutions after treatment with grazoprevir-containing regimens in participants with chronic HCV infection

Frederick Lahser, Angela Galloway, Peggy Hwang, John Palcza, Joann Brunhofer, Janice Wahl, Michael Robertson, Eliav Barr, Todd Black, Ernest Asante-Appiah, Barbara Haber

10.3851/IMP3253


Original article

Is cytomegalovirus a risk factor for haemorrhagic cystitis in allogeneic haematopoietic stem cell transplantation recipients?

Erden Atilla, Merih Yalciner, Pinar Ataca Atilla, Can Ates, Sinem Civriz Bozdag, Meltem Kurt Yuksel, Selami Kocak Toprak, Mehmet Gunduz, Mehmet Ozen, Hamdi Akan, Taner Demirer, Onder Arslan, Osman Ilhan, Meral Beksac, Muhit Ozcan, Gunhan Gurman, Pervin Topcuoglu

10.3851/IMP3252


Original article

An easy-to-use baseline scoring system to predict response to peginterferon alfa-2a in patients with chronic hepatitis B in resource-limited settings

Pietro Lampertico, Diethelm Messinger, Hameed Oladipupo, Georgios Bakalos, Marco Castillo, Tarik Asselah

10.3851/IMP3251


Original article

Comparative effectiveness of 8- and 12-week ledipasvir/sofosbuvir regimens for HCV infection

Rohit P Ojha, Brooke R MacDonald, Tzu-Chun Chu, Esther O Fasanmi, Jonathan D Moore, Rachel A Stewart

10.3851/IMP3249


Page:
Copyright © Nucleus Global 2018. Part of Nucleus Global.
Design and Technology by Nucleus Global
Company registration No. 321 0712 (England & Wales). Registered Office address: Admiral House 76-78 Old Street, London EC1V 9AZ.